REFERENCES
- Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. Guilford Press, New York 1990
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders4th edn. American Psychiatric Association, Washington, DC 1994
- Bauermeister JJ, Canino G, Bird H. Epidemiology of disruptive behavior disorders. Child and Adolescent Psychiatric Clinics of North America, L Greenhill. WB Saunders, Philadelphia 1994; 174–194
- Epstein MH, Cullinan D, Gadow K. Teachers' ratings of hyperactivity in learning‐disabled, emotionally disturbed, and mentally retarded children. Journal of Special Education 1986; 22: 219–229
- Jacobson JW. Problem behavior and psychiatric impairment within a developmentally disabled population I. Behavior frequency. Applied Research in Mental Retardation 1982; 3: 121–139
- Feifel D. Attention‐deficit hyperactivity disorder in adults. Postgraduate Medicine 1996; 100: 207–211
- Fox RA, Wade EJ. Attention deficit hyperactivity disorder among adults with severe and profound mental retardation. Research in Developmental Disabilities 1998; 19: 275–280
- Campbell M, Malone RP. Mental retardation and psychiatric disorders. Hospital and Community Psychiatry 1991; 42: 374–379
- Reid AH, Ballinger BR, Heather BB, Melvin SJ. The natural history of behavioural symptoms among severely and profoundly mentally retarded patients. British Journal of Psychiatry 1984; 145: 289–293
- Aman MG, Singh NN. Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior. Applied Research in Mental Retardation 1982; 3: 345–358
- Thalayasingman SP. Use of methylphenidate in a young adult with intellectual disability and attention‐deficit disorder: a single case report. British Journal of Developmental Disabilities 1999; 45: 63–68
- Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency 1985; 89: 485–491
- National Institute of Mental Health. Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacology Bulletin 1985; 21: 714–1124
- Aman MG. Stimulant drugs in the developmental disabilities revisited. Journal of Developmental and Physical Disabilities 1996; 8: 347–365
- Aman MG, Kern RA, McGhee DE, Arnold LE. Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects. Journal of the American Academy of Child and Adolescent Psychiatry 1993; 32: 851–859
- Sprague RL, Werry JS. Methodology of psychopharmacological studies with the retarded. International Review of Research in Mental Retardation, NR Ellis. Academic Press, New York 1971; 147–219
- Snaith RP, James FE, Winokur B. The drug treatment of mental illness and epilepsy in the mentally handicapped patient. Psychiatric Illness and Mental Handicap, FE James, RP Snaith. Gaskell Press, London 1979; 215–218
- Lund J. Treatment of psychiatric morbidity in the mentally retarded adult. Acta Psychiatrica Scandinavica 1986; 73: 429–436